GovGazette
Menu

Historical award

Xequel Bio, Inc.

This record is historical buying context, not open work.

How current is this award history?

Fiscal year 2025: data through (14 days old).

Fiscal year 2026: data through (14 days old).

Official release availability details

Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Current award value
$999,960.15
Potential award value
$999,960.15
Total obligated to date
$999,960.15

Recorded work

ARMY SBIR MEDICAL R&D CONTRACT FOR "PROPOSAL A2-6647 TITLED, "A NOVEL PEPTIDE-BASED TOPICAL THERAPEUTIC TO PROMOTE CORNEAL REGENERATION AND RESTORE CORNEAL BIOMECHANICS FOLLOWING BLAST AND BURN INJURIES" FIRSTSTRING RESEARCH, INC HAS BEEN ACQUIRED BY XEQUEL BIO. INC.

Award activity

Obligations in covered fiscal years
−$550,000.00
Transactions in covered fiscal years
1

Award value and obligated funds describe different amounts. Review the official record for the full transaction history.

Record identifierCONT_AWD_W81XWH17C0065_9700_-NONE-_-NONE-